A Randomized, Double-Blind Evaluation of the Pharmacokinetics,Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) inChildren and Adolescent Subjects with Chronic Hepatitis B VirusInfection

Project: Research project

Project Details

Description

A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection
StatusActive
Effective start/end date8/13/198/31/24

Funding

  • Gilead Sciences, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.